top of page
Young scientist works in modern biologic

Vitrilife Technology

VitriLife is the 1st commercially scalable vitrification platform enabling industrial scale stabilization of biologicals
Technology Highlights:

  • Scalable and reproducible alternative to lyophilization resulting in superior stabilization.

  • Immobilizes biological materials in a foamed sugar glass matrix.

  • Arrests rotational and translational motion of molecules.

  • Achieves significant increases to product shelf life and improves activity yields.

  • Maintains higher titer after drying and subsequent storage.

  • Reduces storage, packaging, and shipping costs due to potential for ease of the cold chain burden.

  • Enables micronization (milling foam to powder) without product damage.

  • Enables formulation of combination/multi-component products. ​

  • Instantaneous reconstitution at site of delivery.

  • The cornerstone of the VitriLife platform is our patented state-of-the-art drying by boiling process known as preservation by vaporization (PBV).  


Expertise formulating a range of biological products at elevated ambient temperatures: ​

  • Vaccines

  • Monoclonal Antibodies

  • Hormones

  • Growth Factors

  • Therapeutic Proteins

  • Biosimilars

  • Live Biotherapeutic Products (LBPs)

  • Agricultural Biologicals

  • Enzymes

  • Microbiome-based products

How VitriLife compares against other drying technologies?
Screen Shot 2021-09-23 at 4.36.15 PM.png
VitriLife technology allows production in vials or in bulk format
Screen Shot 2021-09-23 at 4.35.26 PM.png
bottom of page